
A Lower-Risk Way To Play This “High-Octane” Healthcare Trend
A lower-risk way to play a “high-octane” healthcare trend is what the nine exchange-traded funds highlighted in today’s article offer. That trend? Biotechnology. And while…

A lower-risk way to play a “high-octane” healthcare trend is what the nine exchange-traded funds highlighted in today’s article offer. That trend? Biotechnology. And while…

While biotech stocks underperformed the broader market in the first half of the year, some names – particularly those focused on neurodegenerative diseases and cancer…

“Today, I’m stepping in with an easy-to-use tool to help you find only the most compelling biotech stocks,” announces the author of today’s article. And…

“We are seeing an opportunity for massive profits in stocks under $10 a share,” declares the author of today’s article, who explains that “As so…

A company that produces slot machines and provides financial equipment and services to casinos, a provider of cloud-based, business-critical communications and storage messaging services, and a broadband provider…

Avoid the market’s most volatile stocks, advises the author of today’s article. In fact, he refers to the market’s top 10% or top 20% most…

“These are four stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential,” says the author of today’s…

The FDA’s approval of Biogen’s Alzheimer’s drug “has set a precedent, showing a much easier path to approval for investigative drug treatments focused on neurodegenerative…

With the current excitement surrounding heavily shorted stocks, the author of today’s article takes a look at a number of current and former penny stocks…

Against a backdrop in which investors remain keen on COVID-19 vaccine stocks such as Moderna and Novavax, and in which Biogen has just received the…